多重肥胖指数表明肥胖和便秘之间存在密切关系:来自NHANESES的证据
Nengjun Xiang1, Lulu Xu2, Haihua Qian3
1Department of Anorectal Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
BMC public health
|May 9, 2024
概括
肥胖会增加便秘的风险,特别是在较高的BMI,腰身高度比和脂质积累产品的情况下. 减少这些肥胖指标可能会降低便秘风险,而更高的体重调整腰部指数显示出保护作用.
科学领域:
- 公共卫生 公共卫生
- 胃肠病学 胃肠病学
- 肥胖医学 肥胖医学
背景情况:
- 便秘是一种普遍的胃肠道问题,影响了相当一部分成年人群.
- 肥胖是一个日益严重的公共卫生问题,有许多相关的并发症.
- 肥胖和便秘之间的关系需要进一步调查,以确定特定的风险因素.
研究的目的:
- 调查各种肥胖指数与美国成年人便秘患病率之间的关联.
- 确定与便秘风险增加或降低相关的特定肥胖指标.
主要方法:
- 利用来自国家健康和营养检查调查 (NHANES) 的数据进行大规模分析.
- 采用多变量逻辑回归,子组分析和受限立方线来评估相关性.
- 研究了身体质量指数 (BMI),腰身高比 (WSR),脂质积累产物 (LAP) 和体重调整腰部指数 (WWI) 与便秘之间的关系.
主要成果:
- 便秘的加权流行率为9.42%.
- 便秘风险增加与BMI>28 kg/m2,WSR在58.3-64.8或>64.8之间,LAP在50.8-90.1.1之间相关.
- 降低便秘风险与第一次世界大战之间的0.015-0.020或>0.020有关,并且没有中心肥胖症. 在BMI,WSR,LAP和便秘之间观察到非线性关系.
结论:
- 减少BMI,WSR,LAP和腰围可能会降低便秘的风险.
- 较高的WWI与较低的便秘风险有关,独立于其他变量.
- 这项研究强调了肥胖指标和便秘之间的复杂相互作用,为有针对性的干预提供了见解.
相关概念视频
Assessment of the Rectum and Anus
202
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
202
Obesity
468
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
468
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Assessment of the Gastrointestinal System II: Health Perception Pattern
105
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
105
Assessment of the Gastrointestinal System I: Subjective Data
182
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
182
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
157
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
157


